Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nicolas M Van Mieghem Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more
Author(s): Howard C Herrmann Added: 2 weeks ago
EuroPCR 2026 – Prof Howard Herrmann (University of Pennsylvania School of Medicine, Philadelphia, PA, US) joins us to discuss three-year outcomes from the SMART trial, evaluating self-expanding versus balloon-expandable transcatheter aortic valve replacement in patients with a small aortic annulus and symptomatic severe native aortic stenosis.This prospective, international, randomised controlled… View more
Author(s): Added: 1 week ago
Dr Virag Kushwaha (Eastern Heart Clinic, New South Wales, AU) joins us to discuss 30-day outcomes of valve-in-valve transcatheter aortic valve replacement using the Navitor system in patients with failed surgical aortic bioprosthetic valves.As the population of patients with ageing surgical bioprostheses continues to grow, valve-in-valve TAVR has become an increasingly important treatment pathway… View more
Author(s): Ole De Backer Added: 11 months ago
New York Valves 2025 - Prof Ole De Backer (Rigshospitalet, Copenhagen, DK) joins us to discuss the current landscape of transcatheter aortic valve replacement (TAVR) in 2025. Prof De Backer highlights the recent trends in current TAVR research and shares his anticipations and hopes for the future of the procedure.Interview Questions:1. What does the TAVR landscape look like in 2025, and how has… View more
Author(s): Sunny Goel Added: 11 months ago
New York Valves 2025 - Dr Sunny Goel (Mount Sinai Hospital, New York, US) joins us to discuss the current devices and strategies that are used for embolic protection and stroke prevention in transcatheter aortic valve replacement (TAVR). Dr Goel highlights the lack of strong guidelines in the field and shares findings from recent studies investigating embolic protection devices.Interview… View more